Interpace Biosciences Inc ROIC
What is the ROIC of Interpace Biosciences Inc?
The ROIC of Interpace Biosciences Inc is 108.21%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with roic similar to Interpace Biosciences Inc
- ESG Global Impact Capital has ROIC of 96.25%
- Davidstea Inc has ROIC of 96.69%
- Onoff AG has ROIC of 97.15%
- ThreeD Capital has ROIC of 97.77%
- Golden Matrix has ROIC of 99.52%
- Boomer has ROIC of 108.06%
- Interpace Biosciences Inc has ROIC of 108.21%
- Hawks Acquisition Corp has ROIC of 108.59%
- Goldflare Exploration Inc has ROIC of 110.33%
- BioNTech SE has ROIC of 110.80%
- National Cinemedia Inc has ROIC of 112.03%
- 48475 has ROIC of 113.60%
- Athena Technology Acquisition II has ROIC of 113.88%